Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: 886715 / Name: AstraZeneca / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Astrazeneca ADR Stock

So far the community has only identified positive things for Astrazeneca ADR stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Astrazeneca ADR in the next few years

Pros
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Astrazeneca ADR vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Astrazeneca ADR - - - - - - -
GSK plc ADR -0.920% -4.072% -15.200% 28.485% 1.435% 26.946% 7.342%
Bayer AG ADR -2.480% 1.105% -7.576% 56.410% 3.977% -31.203% -35.106%
Roche Holding AG ADR 0.430% 0.249% 2.209% 22.859% -0.545% 18.771% 27.740%

News

Innate Pharma Q1 Earnings Call Highlights
Innate Pharma Q1 Earnings Call Highlights

Innate Pharma (NASDAQ:IPHA) said its first-quarter 2026 business update centered on three priority clinical assets: lacutamab in cutaneous T-cell lymphoma, the Nectin-4 antibody-drug conjugate

AstraZeneca and OMP Demonstrate Planning at the Speed of Change at Gartner Supply Chain Symposium/Xpo(TM) 2026
AstraZeneca and OMP Demonstrate Planning at the Speed of Change at Gartner Supply Chain Symposium/Xpo(TM) 2026

How decision velocity closes the gap between insight and action in complex, fast-moving supply chains

 

ANTWERPEN, BE / ACCESS Newswire / May 7, 2026 / OMP, a leader in AI-powered supply

P&G and OMP Showcase the Path to Autonomous, Decision-Centric Planning at Gartner Supply Chain Symposium/Xpo 2026
P&G and OMP Showcase the Path to Autonomous, Decision-Centric Planning at Gartner Supply Chain Symposium/Xpo 2026

How decision velocity is closing the gap between insight and action across one of the world's most complex value chains

 

ATLANTA, GA / ACCESS Newswire / April 14, 2026 / OMP, a leader in